Since 1993, research and publications[5-9] have supported universal screening; now the cost of identifying an infant with hearing loss is less than the cost of identifying an infant with phenylketonuria.[10] Also, studies by Appuzzo and Yoshinaga-Itano[11] and Yoshinaga-Itano and colleagues[12] showed early identification and intervention improves language and social development, and today 37 states have more than 1 hospital providing universal hearing screening programs.[13] A variety of screening devices are used, including automated auditory brainstem responses (AABR),
transient evoked otoacoustic emission, and distortion product otoacoustic emissions (DPOAE).
All examinations were carried out by the same otolaryngologist, after which tympanogram, pure-tone audiometry (PTA), and
transient evoked otoacoustic emission (TEOAE) tests were conducted.
Hearing status in neonatal hyper bilirubinemia by auditory brain stem evoked response and
transient evoked otoacoustic emission. Acta Medica Iranica 2011; 49 (2) 109-112.
Audiometric pure-tone thresholds and
transient evoked otoacoustic emission (TEOAE) levels were determined in both groups.
Identification of neonatal hearing impairment: evaluation of
transient evoked otoacoustic emission, distortion product otoacoustic emission, and auditory brain stem response test performance.
The
transient evoked otoacoustic emission and distortion product otoacoustic emission responses of 38 children with autism were investigated and compared with those of 27 typically developing control subjects.
Transient evoked otoacoustic emissions in patients with middle ear disorders.
Contralateral Suppression of
Transient Evoked Otoacoustic Emissions in Children with Fluency Disorders.
The National Hearing Screening Program for newborns uses the
Transient Evoked Otoacoustic Emissions (TEOAE) and Auditory Brainstem Response (ABR) tests.
Universal newborn hearing screening using
transient evoked otoacoustic emissions: results of the Rhode Island hearing assessment Project.
Distribution of general responses of TEOAE VariableGroups Mean SD Mini Maxi F P mum mum value TEOAE Study 20.41 5.26 12.3 31.4 12.37 .001 * Right Control 28.34 9.96 12.3 45.7 Ear TEOAE Study 21.00 5.62 10.3 35.2 5.48 .023 * Left Control 30.05 18.48 12.3 102 Ear Statistical Method: ANOVA test TEOAE:
Transient evoked otoacoustic emissions SD: Standard deviation F: Frequency P-value.: Significance Table 4.
(13.) Benito-Orejas JI, Ramirez B, Morais D, et al: Comparison of two-step
transient evoked otoacoustic emissions (TEOAE) and automated auditory brainstem response (AABR) for universal newborn hearing screening programs.
